Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies
- PMID: 2457622
Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies
Abstract
Hydrolysis of the internal thioester bond in native C3 is thought to be a key event in initiating the alternative pathway of C activation, because the resulting C3(H2O) acquires "C3b-like" properties. Therefore, disruption of the internal thioester bond is probably accompanied by conformational changes in the C3 molecule. In this study, we demonstrate that such conformational changes indeed occur; 7 of the 19 mAb raised against C3 or C3 activation products recognized epitopes exposed on C3(H2O) but not on native C3. One of these epitopes is located on the C3a part, three on the C3c part, and another three on the C3d,g part. Because the 7 mAb bound equally well to C3 incubated either with MgCl2 or with methylamine (which primarily disrupts the thioester), the conformational changes detected by the mAb apparently occur after disruption of the thioester. Furthermore, the epitopes were also present on the corresponding C3 activation products. Immunoblotting experiments revealed that the epitopes for the three anti-C3d,g mAb were located on the C3d part, C-terminal to the thioester. The epitopes for 2 of the 3 anti-C3c mAb were located on the C-terminal alpha-chain fragment of C3c. Thus, this study provides immunochemical evidence for the biologic resemblance between C3(H2O) and C3 activation products. Implications of these findings for the activation process of C3 are discussed.
Similar articles
-
Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3".J Immunol. 1990 Jun 1;144(11):4249-55. J Immunol. 1990. PMID: 1692860
-
The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.J Immunol. 1988 Jul 15;141(2):553-8. J Immunol. 1988. PMID: 2454995
-
Characterization of three monoclonal antibodies against C3 with selective specificities.Immunology. 1987 Nov;62(3):413-7. Immunology. 1987. PMID: 2444528 Free PMC article.
-
Activation-dependent antigenic changes of human C3.Complement Inflamm. 1989;6(3):205-18. doi: 10.1159/000463094. Complement Inflamm. 1989. PMID: 2472922 Review.
-
The internal thioester and the covalent binding properties of the complement proteins C3 and C4.Protein Sci. 1997 Feb;6(2):263-74. doi: 10.1002/pro.5560060201. Protein Sci. 1997. PMID: 9041627 Free PMC article. Review.
Cited by
-
Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.J Clin Invest. 1991 Aug;88(2):379-84. doi: 10.1172/JCI115314. J Clin Invest. 1991. PMID: 1864952 Free PMC article.
-
A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.Gut. 2004 Sep;53(9):1267-73. doi: 10.1136/gut.2003.037952. Gut. 2004. PMID: 15306583 Free PMC article.
-
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.Blood Adv. 2023 Jul 11;7(13):3128-3139. doi: 10.1182/bloodadvances.2022009402. Blood Adv. 2023. PMID: 36920779 Free PMC article. Clinical Trial.
-
Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease.Front Immunol. 2019 Apr 4;10:703. doi: 10.3389/fimmu.2019.00703. eCollection 2019. Front Immunol. 2019. PMID: 31019515 Free PMC article.
-
Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.Immunology. 1993 Aug;79(4):639-47. Immunology. 1993. PMID: 8406590 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous